Galatea Surgical

Galatea Surgical is a medical technology company focused on developing bioresorbable scaffolds for plastic and reconstructive surgery. A subsidiary of BD (Becton, Dickinson and Company) following its acquisition of Tepha, Inc., the company utilizes a proprietary poly-4-hydroxybutyrate (P4HB) polymer platform. Its flagship products, including GalaFLEX and GalaFLEX Lite, provide temporary internal support to soft tissue during the healing process before being naturally absorbed by the body. These scaffolds are widely used in aesthetic breast procedures to reinforce tissue and promote the formation of new collagen. The technology is designed to bridge the gap between permanent synthetic meshes and rapidly degrading biologic matrices. By offering a scaffold that is replaced by the patient's own tissue, Galatea aims to improve long-term surgical outcomes in mastopexy and breast reduction.